Condition: Breast Cancer · Sponsor: University of Illinois at Chicago
This is a non-randomized, single arm phase 2 trial of oral CMC based on conversion of doses that would be delivered with conventional metronomic CMF chemotherapy.
This description comes directly from the study's public registry record.
Abiola Ibreeheem, MD · 312-413-1581 · abiolai@uic.edu
Prathmika Jha, BS · 312-413-2746 · pjha7@uic.edu
Always discuss trial participation with your own doctor first.
| University of Illinois | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06085742